Objective: To investigate the reciprocal inhibitory effects of hepatitis B virus (HBV)/hepatitis C virus (HCV)/hepatitis D virus (HDV) infections in naive and previously antiretroviral-experienced HIV-positive patients. Design: This retrospective Study involved 72 consecutive patients of the Italian Cohort Naive Antiretroviral cohort: 21 coinfected with HBV/HCV (group IBC), 18 infected with HBV (group 2B), and 33 infected with HCV (group 3C). Methods: Viral interference between HBV and HCV was assessed by means of the qualitative detection, quantification, and genotyping of each virus; HDV infection was assessed by means of genomic amplification. Results: Univariate analysis showed that HBV DNA was less frequently detected in group I BC than in group 213 (16 of 21 vs 18 of 18; P = 0.02), their HBV load was significantly lower (median 3.9 vs 5.4 log(10) HBV DNA copies/mL; P = 0.002), and they more frequently carried HBV genotype D (12 of 13 vs 4 of 11; P = 0.0071). HCV RNA was less frequently detected in group I BC than in group 3C (12 of 21 vs 33 of 33; P 0.0001), and HDV RNA was more frequently detected in group IBC than in group 213 (9 of 21 vs 2 of 18; P = 0.028). Multivariate analysis of the, HBV-infected subjects showed that the risk of HCV coinfection was associated with older age [relative risk 0.28, 95% confidence interval (CI): 0.09 to 0.90; P = 0.033 for every 10 years older] and intravenous drug use (relative risk 73, 95% CI: 2.4 to >999.999; P = 0.013). The only predictor of HBV coinfection in HCV-infected individuals was a lower HCV load (relative risk 0.30, 95% CI: 0.11 to 0.79 for every additional log(10) HCV RNA; P = 0.015). Conclusion: HBV and HCV showed alternative dominant replication in the I.Co.N.A. cohort, with HBV having a more unfavorable effect on HCV replication.

Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients / Giulia, Morsica; Sabrina, Bagaglio; Paola, Cicconi; Maria R., Capobianchi; Giampietro, Pellizzer; Pietro, Caramello; Anna, Orani; Cristina, Moioli; Lichtner, Miriam; Giuliano, Rizzardini; Caterina Uberti, Foppa; Massimo, Puoti; Antonella Dʼarminio, Monforte; Vullo, Vincenzo; I. C. O. N. A., The Icona Foundation Study Groups Hepa. - In: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. - ISSN 1525-4135. - 51:5(2009), pp. 574-581. (Intervento presentato al convegno 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting of the Infectious-Diseases-Society-of-America tenutosi a Washington, DC nel OCT 25, 2008) [10.1097/qai.0b013e3181add592].

Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients

LICHTNER, Miriam;VULLO, Vincenzo;
2009

Abstract

Objective: To investigate the reciprocal inhibitory effects of hepatitis B virus (HBV)/hepatitis C virus (HCV)/hepatitis D virus (HDV) infections in naive and previously antiretroviral-experienced HIV-positive patients. Design: This retrospective Study involved 72 consecutive patients of the Italian Cohort Naive Antiretroviral cohort: 21 coinfected with HBV/HCV (group IBC), 18 infected with HBV (group 2B), and 33 infected with HCV (group 3C). Methods: Viral interference between HBV and HCV was assessed by means of the qualitative detection, quantification, and genotyping of each virus; HDV infection was assessed by means of genomic amplification. Results: Univariate analysis showed that HBV DNA was less frequently detected in group I BC than in group 213 (16 of 21 vs 18 of 18; P = 0.02), their HBV load was significantly lower (median 3.9 vs 5.4 log(10) HBV DNA copies/mL; P = 0.002), and they more frequently carried HBV genotype D (12 of 13 vs 4 of 11; P = 0.0071). HCV RNA was less frequently detected in group I BC than in group 3C (12 of 21 vs 33 of 33; P 0.0001), and HDV RNA was more frequently detected in group IBC than in group 213 (9 of 21 vs 2 of 18; P = 0.028). Multivariate analysis of the, HBV-infected subjects showed that the risk of HCV coinfection was associated with older age [relative risk 0.28, 95% confidence interval (CI): 0.09 to 0.90; P = 0.033 for every 10 years older] and intravenous drug use (relative risk 73, 95% CI: 2.4 to >999.999; P = 0.013). The only predictor of HBV coinfection in HCV-infected individuals was a lower HCV load (relative risk 0.30, 95% CI: 0.11 to 0.79 for every additional log(10) HCV RNA; P = 0.015). Conclusion: HBV and HCV showed alternative dominant replication in the I.Co.N.A. cohort, with HBV having a more unfavorable effect on HCV replication.
2009
01 Pubblicazione su rivista::01a Articolo in rivista
Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients / Giulia, Morsica; Sabrina, Bagaglio; Paola, Cicconi; Maria R., Capobianchi; Giampietro, Pellizzer; Pietro, Caramello; Anna, Orani; Cristina, Moioli; Lichtner, Miriam; Giuliano, Rizzardini; Caterina Uberti, Foppa; Massimo, Puoti; Antonella Dʼarminio, Monforte; Vullo, Vincenzo; I. C. O. N. A., The Icona Foundation Study Groups Hepa. - In: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. - ISSN 1525-4135. - 51:5(2009), pp. 574-581. (Intervento presentato al convegno 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting of the Infectious-Diseases-Society-of-America tenutosi a Washington, DC nel OCT 25, 2008) [10.1097/qai.0b013e3181add592].
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/230169
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 20
social impact